STOCK TITAN

IGM Biosciences to Present at the Truist Securities Life Sciences Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IGM Biosciences, a clinical-stage biotechnology firm, announced that CEO Fred Schwarzer will speak at the Truist Securities Life Sciences Summit on May 4, 2021, at 4:20 p.m. EDT. The summit will occur virtually, and interested parties can access a live webcast on the company’s website. A replay will be available for 90 days post-event. IGM Biosciences focuses on developing engineered IgM antibodies for treating various diseases, leveraging its proprietary technology platform to overcome challenges in IgM antibody production.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Truist Securities Life Sciences Summit on May 4, 2021 at 4:20 p.m. EDT. The conference will be held in a virtual meeting format.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of multiple diseases. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com


FAQ

When is Fred Schwarzer speaking at the Truist Securities Life Sciences Summit?

Fred Schwarzer will speak on May 4, 2021, at 4:20 p.m. EDT.

How can I watch the IGM Biosciences webcast?

The webcast can be accessed on the 'Events and Presentations' page of IGM Biosciences' website.

What is IGM Biosciences' focus?

IGM Biosciences focuses on developing engineered IgM antibodies for treating multiple diseases.

How long will the webcast replay be available?

A replay of the webcast will be available for 90 days following the event.

IGM Biosciences, Inc.

NASDAQ:IGMS

IGMS Rankings

IGMS Latest News

IGMS Stock Data

573.83M
21.80M
35.05%
63.99%
5.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MOUNTAIN VIEW